SynthesisJournal of community health2026
Prevalence of Electronic Cigarette use in Latin America and the Caribbean: A systematic Review and Meta-analysis.
Synthesis in Journal of community health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Electronic cigarette (e-cigarette) use is increasing globally, yet comprehensive prevalence data for Latin America and the Caribbean (LAC) remain limited. We conducted a meta-analysis to estimate the prevalence of e-cigarette use in the LAC region. A comprehensive search was performed in PubMed/Medline, Scopus, Web-of-Science, Embase, SciELO and Virtual-Health-Library, from inception to January 2025. We included observational studies reporting the prevalence of e-cigarette use in the general population of LAC. Pooled prevalence estimates and corresponding 95% confidence intervals (95%CI) were calculated using random-effects meta-analysis models. A total of 82 studies were included, comprising 46 primary studies and 36 reports from international tobacco-related surveys. Lifetime e-cigarette use was highest among adolescents, with a pooled prevalence of 12.5% (95%CI: 9.1%-17.0%; I²=99.5%), compared with 6.4% (95%CI: 2.8%-14.1%; I²=97.5%) in adults. Current e-cigarette use was also most prevalent among adolescents (6.7%; 95%CI: 5.5%-8.3%; I²=99.2%), compared with adults (1.5%; 95%CI: 0.8%-2.9%; I²=98.9%). Adolescent current use varied geographically, ranging from 1.4% (El Salvador) and 2.5% (Mexico) to 14.5% (Jamaica) and 17.2% (Trinidad and Tobago). Meta-regression analysis showed a significant increasing temporal trend in e-cigarette use, with prevalence rising by 0.10% per year (95%CI: 0.01-2.0; p = 0.047), independent of age group. Despite heterogeneity across countries, the prevalence of e-cigarette use in LAC is high, particularly among adolescents, and has increased significantly over time. These findings indicate that e-cigarette use represents a growing public health concern in the region, calling for strengthened regulation, targeted youth prevention, and continuous surveillance.
Indexed as
Identifiers
41996080What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.